
PMC:6640909 / 9066-9182
Annnotations
TEST0
{"project":"TEST0","denotations":[{"id":"31100109-223-229-7132","span":{"begin":113,"end":115},"obj":"[\"19497443\"]"}],"text":"LT-MCS implantation in patients with haemostatic deficiencies and coagulopathies may be considered. IIb B [35–38]"}
MyTest
{"project":"MyTest","denotations":[{"id":"31100109-19497443-28905192","span":{"begin":113,"end":115},"obj":"19497443"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"LT-MCS implantation in patients with haemostatic deficiencies and coagulopathies may be considered. IIb B [35–38]"}
0_colil
{"project":"0_colil","denotations":[{"id":"31100109-19497443-7132","span":{"begin":113,"end":115},"obj":"19497443"}],"text":"LT-MCS implantation in patients with haemostatic deficiencies and coagulopathies may be considered. IIb B [35–38]"}
2_test
{"project":"2_test","denotations":[{"id":"31100109-19497443-28905192","span":{"begin":113,"end":115},"obj":"19497443"}],"text":"LT-MCS implantation in patients with haemostatic deficiencies and coagulopathies may be considered. IIb B [35–38]"}